Journal article
The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
Leigh Ellis, Michael Bots, Ralph K Lindemann, Jessica E Bolden, Andrea Newbold, Leonie A Cluse, Clare L Scott, Andreas Strasser, Peter Atadja, Scott W Lowe, Ricky W Johnstone
Blood | AMER SOC HEMATOLOGY | Published : 2009
Grants
Awarded by National Health and Medical Research Council of Australia
Awarded by Leukemia & Lymphoma Society
Awarded by National Health and Medical Research Council of Australia RDWright Biomedical
Funding Acknowledgements
R.W.J. is a Pfizer Australia Research Fellow and was supported by the National Health and Medical Research Council of Australia (program grant 251608), the Cancer Council Victoria, the Leukemia Foundation of Australia, and the Bennelong Foundation. L. E. was supported by a postgraduate scholarship from the Leukemia Foundation of Australia. M. B. was supported by a Rubicon research grant from Netherlands Organisation for Scientific Research. A. S. was supported by the National Health and Medical Research Council of Australia (program grant 257502; Australia Fellowship) and the Leukemia & Lymphoma Society (New York, NY; Specialized Center of Research grant 7015). C. L. S. was supported by National Health and Medical Research Council of Australia RDWright Biomedical (CDA 406675).